Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George C Mayne

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Cost-effectiveness of Barrett's oesophagus screening and surveillanceLouisa G Gordon, George C Mayne
Cell Biology International|June 15, 2004
Phorbol ester-induced cell death in PC-12 cells overexpressing Bcl-2 is dependent on the time at which cells are treatedMichael A Hahn, George C Mayne
Expert Review of Anticancer Therapy|March 13, 2013
Can miRNA profiling allow us to determine which patients with esophageal cancer will respond to chemoradiotherapy?George C Mayne, Damian J Hussey, David I Watson
ANZ Journal of Surgery|July 5, 2012
COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitorGeorge C Mayne, David I Watson, Damian J Hussey
Current Pharmaceutical Design|October 25, 2012
MicroRNAs and esophageal cancer--implications for pathogenesis and therapyGeorge C Mayne, Damian J Hussey, David I Watson
World Journal of Surgery|March 6, 2007
Barrett's Esophagus, fundoplication, and cancerDavid I Watson, George C Mayne, Damian J Hussey
Annals of Surgical Oncology|October 27, 2018
ASO Author Reflections: Predicting the Response of Esophageal Adenocarcinoma to Chemoradiotherapy Before Surgery Using MicroRNA Biomarkers Offers Hope to Improve Outcomes by Tailoring Treatment to Predicted ResponsesGeorge C Mayne, David I Watson, Karen Chiam, et al.
ANZ Journal of Surgery|August 21, 2012
Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?George C Mayne, Tim Bright, Damian J Hussey, et al.
Expert Review of Gastroenterology & Hepatology|October 16, 2012
Molecular biomarkers and ablative therapies for Barrett's esophagusJacob A Chisholm, George C Mayne, Damian J Hussey, et al.
BMC Bioinformatics|December 11, 2014
A fixed-point algorithm for estimating amplification efficiency from a polymerase chain reaction dilution seriesMichael E Jones, George C Mayne, Tingting Wang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Cost-effectiveness of Barrett's oesophagus screening and surveillanceLouisa G Gordon, George C Mayne
Cell Biology International|June 15, 2004
Phorbol ester-induced cell death in PC-12 cells overexpressing Bcl-2 is dependent on the time at which cells are treatedMichael A Hahn, George C Mayne
Expert Review of Anticancer Therapy|March 13, 2013
Can miRNA profiling allow us to determine which patients with esophageal cancer will respond to chemoradiotherapy?George C Mayne, Damian J Hussey, David I Watson
ANZ Journal of Surgery|July 5, 2012
COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitorGeorge C Mayne, David I Watson, Damian J Hussey
Current Pharmaceutical Design|October 25, 2012
MicroRNAs and esophageal cancer--implications for pathogenesis and therapyGeorge C Mayne, Damian J Hussey, David I Watson
World Journal of Surgery|March 6, 2007
Barrett's Esophagus, fundoplication, and cancerDavid I Watson, George C Mayne, Damian J Hussey
Annals of Surgical Oncology|October 27, 2018
ASO Author Reflections: Predicting the Response of Esophageal Adenocarcinoma to Chemoradiotherapy Before Surgery Using MicroRNA Biomarkers Offers Hope to Improve Outcomes by Tailoring Treatment to Predicted ResponsesGeorge C Mayne, David I Watson, Karen Chiam, et al.
ANZ Journal of Surgery|August 21, 2012
Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?George C Mayne, Tim Bright, Damian J Hussey, et al.
Expert Review of Gastroenterology & Hepatology|October 16, 2012
Molecular biomarkers and ablative therapies for Barrett's esophagusJacob A Chisholm, George C Mayne, Damian J Hussey, et al.
BMC Bioinformatics|December 11, 2014
A fixed-point algorithm for estimating amplification efficiency from a polymerase chain reaction dilution seriesMichael E Jones, George C Mayne, Tingting Wang, et al.
Pageof 4